Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (1256)	7/10/2002 10:01:58 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

Companies with bonds have soft underbellies. Well, it was interesting, summer of '98, listening to a concept that was new to me..... that biotechs, without profits, also have soft underbellies. I sat in front of an analyst and a fund manager, and heard that (1) one has to short in biotech, and (2) companies without sponsorship could be shorted to zero. In summer '98, it hadn't caught on yet. It was possible to fight back with rationale and shallow pockets. Not now. There's just too much money aligned against the sector. The (long) game here will be to ride compelling news, company-by-company. As everyone here knows, the long game is the only one that I'm interested in. Thanks, Wilder. Short the bonds, bash and buy the common. Yet another way to win on the way down and posture for success when the strategy has run its course. Genius. Rotten. :-)